by Truveta staff | Jul 30, 2024 | Technology
In this blog I will discuss our approach to scaling our AI technologies across multiple dimensions while controlling development costs, operational costs, and assuring stability. LLMs are a powerful new technology, but they also have large development, operational,...
by Truveta staff | Jul 1, 2024 | Technology
In this post, I would like to discuss the way we addressed the following challenge: How to ensure that the AI technologies used in our platform have requisite accuracy and explainability while assuring fairness and avoidance of bias Healthcare and life science...
by Truveta staff | Jun 17, 2024 | Data, News, Technology
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
by Truveta staff | May 30, 2024 | Technology
This post is the first of six deep dives I plan to do into the significant technology challenges we have solved at Truveta using the power of AI to enable healthcare research using real-world data. Today I would like to talk about our approach to answering: How to...
by Truveta staff | May 1, 2024 | Data, News, Technology
Today we are excited to announce the availability of expanded concepts from clinical notes — including family history, medication details reported to providers, and complex concepts for a wide range of therapeutic areas from cardiology to rare disease and more –...
by Truveta staff | Apr 25, 2024 | News, Technology
Truveta was named winner of a Gold Stevie® Award for Achievement in Science or Technology, as well as a Silver for Most Innovative Company of the Year in the 22nd Annual American Business Awards® today. The American Business Awards are the U.S.A.’s premier business...
